Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma

Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma

Item
http://www.wikidata.org/entity/Q33385670
Case Example of Dose Optimization Using Data From Bortezomib Dose-Finding Clinical Trials.Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG).A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma.Phase I Clinical Trials in Patients ≥80The expression of the endoplasmic reticulum stress sensor BiP/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphomaProteasome inhibition and combination therapy for non-Hodgkin's lymphoma: from bench to bedsideArsenic trioxide rewires mantle cell lymphoma response to bortezomibBortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons.Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?Bortezomib: a proteasome inhibitor with an evolving role in select subtypes of B-cell non-Hodgkin's lymphoma.Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma.Velcade combinations in mantle cell lymphoma: are we learning anything?
P2860

Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma

Item
http://www.wikidata.org/entity/Q33385670
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phase I trial of fludarabine, ...... ntle cell non-Hodgkin lymphoma
@ast
Phase I trial of fludarabine, ...... ntle cell non-Hodgkin lymphoma
@en
type
label
Phase I trial of fludarabine, ...... ntle cell non-Hodgkin lymphoma
@ast
Phase I trial of fludarabine, ...... ntle cell non-Hodgkin lymphoma
@en
prefLabel
Phase I trial of fludarabine, ...... ntle cell non-Hodgkin lymphoma
@ast
Phase I trial of fludarabine, ...... ntle cell non-Hodgkin lymphoma
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Phase I trial of fludarabine, ...... ntle cell non-Hodgkin lymphoma
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2141.2009.07836.X
P407
P433
P478
P50
P577
P5875
P698
P921
P932